Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03809117 · ClinicalTrials.gov registry record · NA
Film Array Gastrointestinal Panel Compared to Usual Care for ED Evaluation of Infectious Diarrhea
A NA study, sponsored by Andrew Meltzer.
- Terminated
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT03809117: Clinical Trial NA study, sponsored by Andrew Meltzer.
NCT03809117 is a NA study that was terminated before completion, run by Andrew Meltzer. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03809117, a NA study, was terminated before completion, sponsored by Andrew Meltzer.
- TERMINATED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
This research study will test a laboratory test called Film-Array Gastrointestinal (GI) Panel. This GI Panel is a test that can identify the bacteria or viruses that may cause diarrhea. This test will enable the ED doctor to better understand the cause of diarrhea to try to determine the best treatment. The primary objective of this study is to determine if testing ED patients who complain of diarrhea will lead to more optimal use of antibiotics. Optimal use of antibiotics is defined as the most appropriate antibiotic to treat a specified pathogen.
Primary Outcome
Optimal use of antibiotics is defined as the most appropriate antibiotic to treat a specified pathogen. Designated physicians on study staff will retrospectively examine charts of enrolled subjects will evaluate whether the antibiotic chosen by treating clinician was appropriate given GI PCR results.
Interventions
- DIAGNOSTIC_TEST Biofire Film Array Gastrointestinal Panel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2018-11-19 |
| Est. Completion | 2020-09-07 |
| Phase | NA |
Why NCT03809117 stopped before completion
NCT03809117 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Biofire Film Array Gastrointestinal Panel is the first listed.
NCT03809117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03809117 about?
NCT03809117 is a clinical study titled "Film Array Gastrointestinal Panel Compared to Usual Care for ED Evaluation of Infectious Diarrhea". This research study will test a laboratory test called Film-Array Gastrointestinal (GI) Panel. This GI Panel is a test that can identify the bacteria or viruses that may cause diarrhea. This test will enable the ED doctor to better understand the cause of diarrhea to try to determine the best treatm...
What is the current status of trial NCT03809117?
This trial is currently terminated. It is a NA study. The enrollment target is 74 participants. The study started on 2018-11-19. Estimated completion is 2020-09-07.
What interventions are being tested in trial NCT03809117?
The interventions under investigation include: Biofire Film Array Gastrointestinal Panel (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03809117?
This trial is sponsored by Andrew Meltzer, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03809117's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI